Patrick J. Mahaffy
Director · Medicus Pharma Ltd.
Individual
- 2026
- Jun 4, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Patrick J. Mahaffy's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Patrick J. Mahaffy?
Patrick J. Mahaffy is a corporate insider, tracked as Director of Medicus Pharma Ltd. (MDCX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Patrick J. Mahaffy last file a Form 4?
The most recent primary Form 4 on record is dated 4 June 2026, one of 2 filings going back to 2026.